A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ฿6,519.2, with a 24-hour trading volume of ฿7.44B. The asset's market cap is ฿10.11T, after moving 2.16% in the last day.
Tokenized AstraZeneca PLC is trading at ฿3,289.19, with a tokenized market cap of ฿450.57M and a 24-hour trading volume of ฿12.78M. The tokenized asset has moved 0.54% in the past 24 hours.